首页> 美国政府科技报告 >Human CD1d-Restricted Natural Killer T (NKT) Cell Cytotoxicity Against Myeloid Cells
【24h】

Human CD1d-Restricted Natural Killer T (NKT) Cell Cytotoxicity Against Myeloid Cells

机译:人类CD1d限制性自然杀伤T(NKT)细胞对骨髓细胞的细胞毒性

获取原文

摘要

CD1d-restricted natural killer T cells (NKT cells) are a unique subpopulation of T lymphocytes that have been shown to be able to promote potent anti-tumor responses in a number of different murine (mouse) cancer models, Little is known about whether they may play a role in preventing or controlling human cancers and in particular there is little information about whether they can function to kill cancer cells as they arise Iin vivot (in the body) However it is clear that tin vitrot (in the test tube) NKT cells have the capacity to kill other cells that have a molecule called CD1d on their cell surface, One of the main human cell types that have CDId on the cell surface are cells of the myeloid lineage Thus we believe that NKT cells may have special potential for treating CML because they may be able to kill these tumor cells and it may be possible to devise a protocol to specifically stimulate the NKT cells to kill CML tumor cells as they begin to proliferate.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号